Levocetirizina Sandoz (Levocetirizine Dihydrochloride)

Levocetirizine selectively blocks peripheral histamine H1 receptors. By preventing histamine from binding to these receptors, it inhibits the cascade that leads to vasodilation, increased vascular permeability, and nerve stimulation, thereby diminishing itching, swelling, sneezing, and nasal discharge.

The appropriate dose of Levocetirizina Sandoz is determined by the prescribing clinician based on the patient’s age, weight, renal function, and specific indication. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for levocetirizine in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against possible risks before prescribing to pregnant or nursing women, and discuss alternative options when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Levocetirizine is the active enantiomer of cetirizine, offering similar efficacy with a potentially lower incidence of sedation. Compared with first‑generation antihistamines, it provides better selectivity for H1 receptors and fewer anticholinergic side effects, making it a preferred option for many patients.

Store the tablets at temperatures below 25 °C in their original packaging, protecting them from moisture and direct sunlight. Do not refrigerate or freeze the product, and keep it out of reach of children.

Levocetirizina Sandoz is taken orally, usually once daily, with or without food, as directed by a healthcare professional. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed.

Serious adverse reactions, though rare, include angioedema, anaphylaxis, severe skin reactions such as Stevens‑Johnson syndrome, significant tachycardia, hepatic injury, and hematologic disorders like agranulocytosis. Patients should seek immediate medical attention if they experience any of these symptoms.

Individuals with known hypersensitivity to levocetirizine, other H1‑antihistamines, or any excipients in the formulation should avoid the product. Caution is also advised for patients with severe renal impairment, as dose adjustment may be required.